Estimands and their Estimators for Clinical Trials Impacted by the COVID-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions (2022)

First Author: Van Lancker K

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/19466315.2022.2094459

Publication URI: http://dx.doi.org/10.1080/19466315.2022.2094459

Type: Journal Article/Review

Parent Publication: Statistics in Biopharmaceutical Research

Issue: 1